| |
Common Lineage Suggested for Viruses that Infect Hosts from All
Three Domains of Life (PHILADELPHIA
- December 2, 2004) - Scientists at The Wistar Institute,
working in collaboration with colleagues at the University of Helsinki,
have discovered structural similarities among viruses that infect
hosts from all three domains of life. These structural similarities
suggest that the viruses, despite their genomic variations and
differences in hosts, may have evolved from a common ancestor billions
of years ago. The findings will be published in the December 3
issue of Molecular Cell.
Until recently, scientists have tended to view the viral universe as unrelated
families of viruses, with little attention given to their similarities. "People
tended to concentrate on a single type of virus," says Roger M. Burnett, Ph.D.,
senior author of the study and professor in Wistar's immunology program. "It
hadn't been appreciated until a few years ago that there are great structural
similarities among seemingly unrelated viruses."
The research builds on earlier work by Burnett and his colleagues, in which they
determined the structure of a virus called PRD1 that infects bacteria. They
found that it has remarkable structural similarities to human adenoviruses, which
cause various diseases, including respiratory infections. Using data from their
own and other laboratories, the researchers have created structure-based models
to demonstrate structural similarities in the coats - proteins and architecture
- among viruses that infect hosts from all three domains of life. The three domains
are eukarya (animals, plants, and other higher order organisms); bacteria; and
archaea (a recently described group of microorganisms that differ from bacteria
and are commonly found in extreme environments like geysers, and alkaline, acidic
or salty waters).
It is difficult to study viral evolution, Burnett says, because viruses live
symbiotically with their hosts and adopt host-related traits. Instead of being
inherited from a viral ancestor, these host-related traits may be picked up from
the host or other microorganisms. For viruses that diverged from a common ancestor
billions of years ago, and so have significant differences in genome size, genetic
complexity, and host, structural similarities may be the only evidence remaining
that indicates a shared lineage.
While viral lineage is in itself a question that interests scientists, research
in this area may ultimately inform anti-viral drug discovery. Structural similarities
in viruses may point to sites of enzymatic activity that could be targeted with
drugs. For example, in two of the viruses studied, one vertex of the apparently
symmetric coat is different and used for DNA packaging. With this knowledge in
mind, researchers could explore whether human viruses with similar coat proteins
also have a unique vertex devoted for DNA packaging. If so, new anti-virals
could be developed to target this mechanism.
In addition to senior author Burnett, the other authors of the study are: Stacy
D. Benson, Ph.D., formerly of Wistar and now an assistant professor of chemistry
at Oklahoma State University, and Jaana K.H. Bamford, Ph.D., and Dennis H. Bamford,
Ph.D., both of the University of Helsinki.
Funding for the research was provided by the National Institutes of Health; the
Human Frontiers Science Program; the Commonwealth Universal Research Enhancement
Program, Pennsylvania Department of Health; and the Academy of Finland.
The Wistar Institute is an independent nonprofit biomedical research institution
dedicated to discovering the causes and cures for major diseases, including cancer,
cardiovascular disease, autoimmune disorders, and infectious diseases. Founded
in 1892 as the first institution of its kind in the nation, The Wistar Institute
today is a National Cancer Institute-designated Cancer Center - one of only eight
focused on basic research. Discoveries at Wistar have led to the development
of vaccines for such diseases as rabies and rubella, the identification of genes
associated with breast, lung, and prostate cancer, and the development of monoclonal
antibodies and other significant research technologies and tools.
News releases from The Wistar Institute are available to reporters by direct
e-mail or fax upon request. They are also posted electronically to Wistar's home
page (http://www.wistar.upenn.edu), to EurekAlert! (http://www.eurekalert.org), an Internet resource sponsored
by the American Association for the Advancement of Science, and to the public
interest newswire AScribe (http://www.ascribe.org).
###
|
|